Waterlands VivaNeo and The Fertility Partnership Merge
Hamburg/Frankfurt/Stockholm/Oxford — VivaNeo, a group of fertility centers in the portfolio of Waterland Private Equity (“Waterland”), and The Fertility Partnership, a corporate investment of investor Impilo, are joining forces.
Waterland had acquired the Kinderwunschzentrum Wiesbaden in 2011 — the starting point for the development of VivaNeo. To date, VivaNeo has developed into one of Europe’s leading groups of fertility centers with 15 locations in Germany, Denmark, Austria and the Netherlands. VivaNeo currently generates annual sales of around 50 million euros. As part of the transaction, Waterland will sell its VivaNeo shares to The Fertility Partnership. Further financial details of the transaction were not disclosed.
VivaNeo employs around 300 people in its Europe-wide network of clinics. The group is led by a team of experts with commercial and medical backgrounds, as well as experienced physicians and renowned embryologists. Every year, around 25,000 patients make use of the Group’s broad portfolio of services. VivaNeo’s services are based on laboratory diagnostics, the use of the latest technologies and personalized advice on all facets of reproductive medicine. A systematic exchange of knowledge between the individual clinics creates the basis for the broad range of services and their continuous further development.
With the acquisition of the Wiesbaden fertility center in 2011 and its rebranding as VivaNeo, Waterland launched its buy & build program from this platform. Still in 2011, VivaNeo expanded with the acquisition of a branch office in Berlin. In 2012, further German subsidiaries were added, as well as a sperm bank and a laboratory diagnostics center. The integration of Medisch Centrum Kinderwens in the Netherlands also marked the first step towards internationalization in 2012. Acquisitions in Denmark and Austria followed in 2015 and 2017. They shape the current profile of VivaNeo: 15 locations in Germany, the Netherlands, Denmark and Austria. Throughout Waterland’s investment period, VivaNeo has successfully completed a total of 12 acquisitions, massively increasing its market share and selectively expanding its regional presence.
“Since the start of our buy & build strategy at VivaNeo in 2011, we have accompanied numerous acquisitions at VivaNeo. Their successful integration created a multinational group of fertility centers in the Central European market. During Waterland’s involvement, VivaNeo was able to achieve important milestones in the development of reproductive medicine and significantly improve standards of patient care in the field of infertility treatment and artificial insemination,” says Dr. Carsten Rahlfs, Managing Partner at Waterland Private Equity. “We are pleased to announce the merger of VivaNeo and The Fertility Partnership. This will create a leading European group. The new group aims to invest even more in services and medical treatment quality. In total, the group will have 19 IVF clinics in six European countries.”
“Through a targeted growth strategy, we have been able to significantly expand VivaNeo’s regional footprint and successfully drive the Group’s expansion in a focused manner. We thank Waterland for its partnership support throughout the investment period. Together with The Fertility Group and Impilo, we are now looking forward to entering the next growth phase,” says Sebastian Ahrens, CEO of VivaNeo.
“The Fertility Partnership is already a market leader in the UK and Poland in the areas of IVF as well as ultrasound examinations. Thanks to VivaNeo’s strong Central European presence, we are now the number one IVF provider in Northern Europe. Together, we now want to build a pan-European group to share expertise, experience and existing knowledge in the IVF field,” adds Andrew Came, CEO of The Fertility Partnership.
Independent investment firm Waterland Private Equity has extensive experience in the healthcare sector. Part of the Waterland portfolio in Germany are, for example, ATOS, a group of somatic acute-care hospitals specializing in cutting-edge orthopedic medicine, and the care service provider Schönes Leben Group, a service platform for outpatient, inpatient and open geriatric care as well as mobile services, assisted living and leisure activities. Waterland has been active in this sector in Germany since 2011 through the establishment of MEDIAN, the current market leader in rehabilitation medicine.
Advisors Waterland: Quarton International AG (M&A) and Willkie Farr & Gallagher (Legal)
VivaNeo is a leading provider of infertility treatments in Europe with locations in Austria, Denmark, Germany and the Netherlands. The Group operates a total of nine specialist clinics for artificial insemination in these four countries, as well as a sperm bank, a laboratory for blood diagnostics and its own dialysis clinic. In the countries where VivaNeo is active, VivaNeo is either the market leader or in second place in the market comparison. VivaNeo places the utmost importance on first-class patient care and medical treatment success. https://vivaneo-ivf.com/de/kinderwunschzentren/
About The Fertility Partnership
The Fertility Partnership, with locations in the UK and Poland, is a leading European provider of artificial insemination, ultrasound examinations for pregnant women and hormone treatments. In addition to eight IVF clinics in the UK and 27 additional sites and two IVF clinics in Poland, TFP also operates 88 ultrasound clinics in the UK and an increasing number of hormone treatment centers. Founded in 2012 through the merger of two IVF clinics, TFP has since grown through targeted add-on acquisitions, greenfield developments and expansion into adjacent service sectors. Today, TFP is the largest provider of fertility services in the UK, as well as the third largest in Poland, and is the leader in ultrasound scans in the UK. https://www.thefertilitypartnership.com/
Waterland is an independent private equity investment firm that helps companies realize their growth plans. With substantial financial support and industry expertise, Waterland enables its portfolio companies to achieve accelerated growth both organically and through acquisitions. Waterland has offices in the Netherlands (Bussum), Belgium (Antwerp), Germany (Hamburg, Munich), Poland (Warsaw), the UK (Manchester), Denmark (Copenhagen) and Switzerland (Zurich). Currently, six billion euros in equity funds are under management.
Waterland has consistently outperformed its investments since its founding in 1999 and has regularly ranked among the top three leading private equity firms worldwide in past HEC/Dow Jones Private Equity Performance Rankings.